Sg3 Management, LLC Zynerba Pharmaceuticals, Inc. Call Options Transaction History

Sg3 Management, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2020 Nov 13, 2020	SELL	$3.23 - $4.3 $597,550 - $795,500	-185,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $612,350 - $1.21 Million	185,000 New	185,000 $623,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.